From theheart.org on Medscape

Medscape Medical News from the

American College of Cardiology (ACC) 2014 Scientific Sessions

March 29 - 31, 2014; Washington, DC

This coverage is not sanctioned by, nor a part of, the American College of Cardiology.

The Cardiology Show

The Cardiology Show from ACC 2014 With Dr Valentin Fuster UPDATED with Transcript // Dr Valentin Fuster reviews CoreValve, renal denervation, STAMPEDE, and LAPLACE-2, and gains insights from panelists Drs Blumenthal, Messerli, Gardner, Walsh, and Watson.

Meeting Highlights at a Glance

Top News From ACC 2014: Slideshow Highlights include the latest results from the HEAT-PPCI, MADIT-CRT, and REGARDS trials, and more.

Conference News

ACC POISE-2: ASA, Clonidine Don't Protect in Noncardiac Surgery
Heartwire from Medscape, April 8, 2014
ACC MSC Trial: Stem-Cell Therapy for Ischemic HF Inches Forward
Heartwire from Medscape, April 4, 2014
ACC Bivalirudin Bleeding? More from NAPLES III, BRAVE 4, BRIGHT
Heartwire from Medscape, April 4, 2014
ACC Most ICD Athletes Can Play Sports Without Cardiac Risks
Heartwire from Medscape, April 3, 2014
ACC GIPS-III Trial: Diabetes Drug Metformin No Benefit in STEMI
Medscape Medical News, April 3, 2014
ACC Risk-Tailored DAPT Boosts DES Safety in Difficult Patient Group
Heartwire from Medscape, April 3, 2014
ACC Darapladib Fails to Reduce CVD Risk in STABILITY
Heartwire from Medscape, April 2, 2014
ACC HEAT-PPCI: Heparin Bests Bivalirudin in STEMI, Amid Heated Debate
Heartwire from Medscape, April 1, 2014
ACC Not Today: Cardiologists, MOC Deadline Extended to April 30
Heartwire from Medscape, April 1, 2014
ACC One-Year TAVR Mortality and Stroke Data Reassures
Heartwire from Medscape, April 1, 2014
ACC In Chest Pain, hs-cTnT Again Shows Promise for MI Rule-Out
Heartwire from Medscape, March 31, 2014
ACC Heart-Failure Data for Alogliptin Prompt More Debate at ACC
Medscape Medical News, March 31, 2014
ACC Registry Data Keep Renal Denervation Debate Going
Heartwire from Medscape, March 31, 2014
ACC STAMPEDE: Bariatric Surgery Betters Meds in Obese Diabetics
Medscape Medical News, March 31, 2014
ACC PCSK9 Inhibitors Showing Big Results in Early Trials
Heartwire from Medscape, March 30, 2014
ACC Are ICD Patients Who Drive Post-VT Ticking Time Bombs?
Heartwire from Medscape, March 30, 2014

ACC Colchicine Cuts Multiple Recurrences of Pericarditis: CORP 2
Heartwire from Medscape, March 30, 2014
ACC CHOICE: Sapien Bests CoreValve for 'Device Success'
Heartwire from Medscape, March 30, 2014
ACC CRT Survival Gains in Mild HF Durable at 7 Years: MADIT-CRT
Heartwire from Medscape, March 30, 2014
ACC All That Glitters Is Not Gold: AleCardio Dissected at ACC
Medscape Medical News, March 30, 2014
ACC REGARDS Analysis Answers Critics of New CV-Risk Equations
Heartwire from Medscape, March 29, 2014
ACC Celiac Disease Linked to Almost Doubled Risk of CAD
Heartwire from Medscape, March 29, 2014
ACC As Statins Boost Erectile Function, Adherence May Rise Too
Heartwire from Medscape, March 29, 2014
ACC Two-a-Day Diet-Drink Habit Ups CVD Odds in Older Women
Heartwire from Medscape, March 29, 2014
ACC CoreValve Beats High-Risk Surgery for AV Stenosis
Heartwire from Medscape, March 29, 2014
ACC SYMPLICITY HTN-3: Renal Denervation Fails in Major Study
Heartwire from Medscape, March 29, 2014
ACC CVD Lowest in Married Couples, Highest in Widowed, Divorced
Heartwire from Medscape, March 28, 2014
ACC Number of Births Linked With Atherosclerosis Risk
Heartwire from Medscape, March 28, 2014
ACC Fruits and Vegetables Lower CAC Burden in Women
Heartwire from Medscape, March 28, 2014
ACC One-Third of Children Tested Have Borderline or High Cholesterol
Heartwire from Medscape, March 28, 2014
ACC What's Going to Be Hot at ACC 2014
Heartwire from Medscape, March 26, 2014

Perspectives from ACC

Intervening in the Elderly: First, Do No Harm
Timothy Gardner, MD; Franz Messerli, MD; Mary Norine Walsh, MD
Hypertension Insights With Drs. Messerli and Watson
Franz H. Messerli, MD; Karol E. Watson, MD, PhD
Surgical Takeaways From ACC 2014
Timothy J. Gardner, MD
Lower the Salt, and the Blood Pressure Will Follow
Michael A. Weber, MD; Daniel T. Lackland, DrPH
Do We Need to Measure Drug Levels of NOACs?
Samuel Z. Goldhaber, MD; Christian T. Ruff, MD, MPH
Registry vs RCT Data on Renal Denervation
Felix Mahfoud, MD
Cholesterol Management 2014: Any Role for Nonstatins?
Melissa Walton-Shirley, MD; Roger S. Blumenthal, MD; Karol E. Watson, MD, PhD
FDA Approval 2.0: Dr. Kandzari Interviews Dr. Bill Maisel
David E. Kandzari, MD; William H. Maisel, MD, MPH
CV Risk Calculator and Lipid Guidelines: The Future Is Bright
Neil J. Stone, MD
LAPLACE-2: The Place of Evolocumab in the Age of Statins?
Jennifer G. Robinson, MD, MPH
Confessions of a SYMPLICITY HTN-3 Trialist
Seth Bilazarian, MD
The SYMPLICITY HTN-3 Co-PI Gives His 2 Cents
George L. Bakris, MD
SEATTLE-II: A New Era for Massive and Submassive PE
Samuel Z. Goldhaber, MD; Gregory Piazza, MD
Heart Failure Lessons From ACC 2014
Ileana L. Piña, MD, MPH
HEAT-PPCI: Two Different Points of View
Robert A. Harrington, MD; E. Magnus Ohman, MD
Dana Carvey and Dr. P.K. Shah on Patient-Physician Relationships
Dana Carvey; Prediman K. Shah, MD; Tricia Ward
BRAVE-4 and HEAT-PPCI: Bivalirudin Takes a Hit
Robert A. Byrne, MB, BCh, PhD; Adeel Shahzad, MBBS, MRCP; Rodney H. Stables, DM, FRCP
HEAT-PPCI and the Ethics of Delayed Consent
Robert A. Byrne, MB, BCh, PhD; Adeel Shahzad, MBBS, MRCP; Rodney H. Stables, DM, FRCP
Call Time-out for the ABIM MOC Mandate
John Mandrola, MD

Live Blog

News and Views from ACC 2014 Coverage of key advances and expert reactions as they happened at the meeting.

Blogger from the Floor

Things That Make You Go Hmm, Part 2: SAVR vs TAVR Cost and Deciding What's Best Dr Melissa Walton-Shirley summarizes other presentations on TAVR and SAVR and their costs, complications, and implications.
Things That Make You Go Hmm, Part I: TAVR for Bicusps? Dr Melissa Walton-Shirley ponders the TAVR-SAVR decision and factors that influence it and describes new expansions for TAVR into bicuspid valves and their implications.
Calcium Scoring: Justified! Dr Melissa Walton-Shirley reports on a series of presentations on CAC screening, noting that "we finally got a real glimpse of the future of calcium scoring."
HF Readmission Rates: Seriously! It shouldn't have taken the threat of monetary loss, a president, or malpractice to get our attention, but it's still satisfying to see nearly every single driver of HF readmission being picked apart.

Previous Coverage